ATXI - Avenue Therapeutics GAAP EPS of -$0.98 misses by $0.01
2024-03-18 16:46:33 ET
More on Avenue Therapeutics
- Avenue Therapeutics granted extension for Nasdaq compliance
- Avenue Therapeutics signs warrant exercise transactions for $5.0M in proceeds
- Seeking Alpha’s Quant Rating on Avenue Therapeutics
- Historical earnings data for Avenue Therapeutics
- Financial information for Avenue Therapeutics